Arrowhead Stock: RNAi Specialist Struggling To Show A Strong Hand (NASDAQ:ARWR) | Old North State Wealth News
Connect with us

Investing

Arrowhead Stock: RNAi Specialist Struggling To Show A Strong Hand (NASDAQ:ARWR)

Published

on

justinkendra/iStock via Getty Images

Investment Overview

Back in 2019 I covered Arrowhead Pharmaceuticals (NASDAQ:ARWR), a drug developer focused on RNA-interference therapeutics in a note for Seeking Alpha.

The note still provides an accurate overview of Arrowhead’s history, from acquiring RNAOTCQX:RHHBYNVSAMGNJNJ

Read the full article here

Trending

Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.